Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
167 studies found for:    "Poliomyelitis"
Show Display Options
Rank Status Study
21 Completed Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan
Condition: Poliomyelitis
Interventions: Drug: Zinc Sulfate;   Drug: Placebo
22 Completed Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine
Condition: Poliomyelitis
Interventions: Biological: Vaccination with inactivated polio vaccine;   Procedure: Collection of serum
23 Completed Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
Conditions: Acellular Pertussis;   Poliomyelitis;   Diphtheria;   Tetanus
Intervention: Biological: BoostrixTM Polio
24 Completed Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children
Conditions: Acellular Pertussis;   Poliomyelitis;   Tetanus;   Diphtheria
Interventions: Biological: Boostrix PolioTM;   Biological: RepevaxTM;   Biological: PriorixTM
25 Completed Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine
Conditions: Hepatitis B;   Diphtheria;   Haemophilus Influenzae Type b (Hib);   Poliomyelitis;   Pertussis;   Tetanus
Interventions: Biological: DTPa-HBV-IPV/Hib (Infanrix hexa™);   Biological: OPV
26 Completed Polio NID and Routine EPI Integration Trial Pakistan
Condition: Polio
Interventions: Behavioral: Vaccine promotion messages;   Other: Vaccination Verification.;   Other: Distribution of Plastic Pouches to retain vaccination card
27 Active, not recruiting Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh
Conditions: Rotavirus Diarrhea;   Polio Serum Neutralizing Antibody;   Polio Vaccine Virus Shedding;   Tropical Enteropathy
Interventions: Biological: IPV;   Biological: Rotarix
28 Completed Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix™) in Infants
Condition: Poliomyelitis
Intervention: Biological: Poliorix™
29 Completed Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Polio
Intervention: Drug: Boostrix polio
30 Completed Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)
Condition: Post Polio Syndrome, PPS
Intervention: Drug: Xepol
31 Completed Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: Concomitant administration;   Biological: Separate administration
32 Completed Glutathione and Health With Post-Polio Syndrome
Conditions: Post-polio Syndrome;   Physical Activity;   Depression;   Pain;   Sleep Disorders
Intervention: Dietary Supplement: Glutathione
33 Active, not recruiting Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
Conditions: Poliomyelitis;   Tropical Enteropathy
Intervention: Biological: IPV vaccination
34 Recruiting Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
Condition: Post-polio Syndrome
Interventions: Biological: Flebogamma 5% DIF;   Other: Placebo
35 Completed Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE
Conditions: Diphtheria;   Tetanus;   Poliomyelitis
Intervention: Biological: Diphtheria, tetanus, polio and pertussis vaccination
36 Completed Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines
Conditions: Immunity to Oral Rotavirus Vaccine;   Immunity to Oral Polio Vaccine;   Shedding of Oral Rotavirus Vaccine
Intervention: Biological: Rotavirus vaccine (Rotarix), oral polio vaccine (Bio-polio), zinc supplement and probiotic supplement (Culturelle)
37 Completed Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults
Condition: Poliomyelitis
Interventions: Drug: IPV;   Drug: Sabin-IPV;   Drug: Adjuvanted Sabin-IPV
38 Recruiting Regulatory Post-Marketing Surveillance Study for TETRAXIM™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
39 Completed Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine
Conditions: Poliomyelitis;   Diphtheria;   Pertussis;   Tetanus
Intervention: Biological: Boostrix-Polio
40 Completed Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly
Condition: Poliomyelitis
Intervention: Biological: Inactivated Poliomyelitis vaccine (IMOVAX)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years